/
 Ankylosing Spondylitis Introduction  Ankylosing Spondylitis Introduction

Ankylosing Spondylitis Introduction - PowerPoint Presentation

ellena-manuel
ellena-manuel . @ellena-manuel
Follow
347 views
Uploaded On 2020-04-04

Ankylosing Spondylitis Introduction - PPT Presentation

Microbiome in Offspring of AS Patients Associations of HLAB Alleles Enthesitis and Peripheral Arthritis in AS Associations of HLAB Alleles Enthesitis and Peripheral Arthritis in AS How Does HLA Type Impact the Pathogenesis of Spondyloarthritis ID: 775444

patients ixekizumab axspa enthesitis patients ixekizumab axspa enthesitis hla active trial secukinumab arthritis peripheral abbreviations associations radiographic alleles

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " Ankylosing Spondylitis Introduction " is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Ankylosing Spondylitis

Slide2

Introduction

Slide3

Microbiome in Offspring of AS Patients

Slide4

Associations of HLA-B Alleles, Enthesitis, and Peripheral Arthritis in AS

Slide5

Associations of HLA-B Alleles, Enthesitis, and Peripheral Arthritis in AS

Slide6

How Does HLA Type Impact the Pathogenesis of Spondyloarthritis?

Slide7

Role of MRI in the Diagnosis of axSpA

Slide8

Secukinumab Provides Sustained Improvement of Enthesitis in Patients With AS

Slide9

PREVENT Study: Secukinumab in Non-Radiographic axSpA

Slide10

IBD and AAU in Patients With AS Treated with Ixekizumab

Slide11

Ixekizumab in AS Including Patients Re-randomized From Adalimumab to Ixekizumab

Slide12

COAST-X Trial: Ixekizumab in Non-Radiographic axSpA

Slide13

2019 ACR/SAA/SPARTAN Recommendations for the Treatment of AS and nr-axSpA

Slide14

Bimekizumab in Patients with Active AS

Slide15

SELECT AXIS 1 Trial: Upadacitinib in Patients With Active AS

Slide16

TORTUGA Trial: Filgotinib* in Patients With Active AS

Slide17

Concluding Remarks

Slide18

Abbreviations

Slide19

Abbreviations (cont)